Predicting Prognosis and Adverse Events by Hematologic Markers in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy

PURPOSE: Our purpose was to evaluate the association between hematologic markers and mortality and adverse events in patients with esophageal squamous cell carcinoma (ESCC) treated with neoadjuvant chemoradiotherapy (nCRT). PATIENTS AND METHODS: A total of 311 patients with ESCC treated with nCRT fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Guoxin, Yu, Jinming, Meng, Xue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519412/
https://www.ncbi.nlm.nih.gov/pubmed/33061564
http://dx.doi.org/10.2147/CMAR.S257058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519412/
https://www.ncbi.nlm.nih.gov/pubmed/33061564
http://dx.doi.org/10.2147/CMAR.S257058

Ejemplares similares